You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Claims for Patent: 11,369,566

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,369,566

Title:	Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Abstract:	Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Inventor(s):	Lichter; Jay (Rancho Santa Fe, CA), Trammel; Andrew M. (Olathe, KS), Piu; Fabrice (San Diego, CA), Ye; Qiang (San Diego, CA), Dellamary; Luis A. (San Marcos, CA), Lebel; Carl (Malibu, CA), Harris; Jeffrey P. (La Jolla, CA)
Assignee:	ALK-ABELLO, INC. (Bedminster, NJ) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA)
Application Number:	15/710,727
Patent Claims:	1. An otic pharmaceutical composition for use in the treatment of an otic disease or condition, comprising an auris acceptable hydrogel and a micronized and non-microencapsulated antimicrobial agent, wherein the composition is free of corticosteroid, wherein the composition is free of preservative, and wherein the composition provides sustained release of the antimicrobial agent into the ear for a period of at least 5 days, and wherein the antimicrobial agent is an antibiotic selected from a sulfonamide, a penicillin, a quinolone, a cephalosporin, or a macrolide antibiotic. 2. The composition of claim 1, wherein the composition is injectable with a needle having a gauge in the range of 18-31. 3. The composition of claim 1, wherein the composition has a viscosity between about 15,000 cP and about 1,000,000 cP. 4. The composition of claim 1, wherein the composition has a pH of about 7.0 to about 8.0. 5. The composition of claim 1, wherein the antibiotic is a quinolone selected from ciprofloxacin, enoxacin, gatifloxacin, levofloxacin, lomefloxacin, moxifloxacin, norfloxacin, ofloxacin, trovafloxacin, grepafloxacin, sparfloxacin, AL-15469A, and AL-38905. 6. The composition of claim 1, wherein the otic disease or condition is otitis media. 7. The composition of claim 1, wherein the otic disease or condition is otitis media with effusion. 8. The composition of claim 1, wherein the otic disease or condition is swimmer's ear. 9. The composition of claim 1, wherein the antibiotic is ciprofloxacin.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.